Ipsen is spreading its bets in a fast-growing and competitive area of cancer drug research, striking a deal for a novel Foreseen Biotechnology antibody drug conjugate (ADC) that’s on track for its ...
**NM signifies a non meaningful value. A dash signifies the data is not available.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results